Dana R. Van De Hey

Statistics

Publications

Citations

320

H-Index

Active since

2015

Affiliations

William S. Middleton Memorial Veterans Hospital(Current)

University of Wisconsin–Madison

University of Wisconsin Carbone Cancer Center

Dana R. Van De Hey is an author at William S. Middleton Memorial Veterans Hospital specializing in medicine, oncology, and oncogenic signaling pathways.

ORCID

Publications per year

2015–2018

Publications

Versican-Derived Matrikines Regulate Batf3–Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer

Chelsea Hope, Philip B. Emmerich, Athanasios Papadas et al. · The Journal of Immunology · 2017 · 108 citations · Full text

Medicine, Immunology, Oncology +17

PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors

Susan N. Payne, Molly E. Maher, Nguyen H. Tran et al. · Oncogenesis · 2015 · 76 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations

Tyler M. Foley, Susan N. Payne, Cheri A. Pasch et al. · Molecular Cancer Research · 2017 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +17

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

Stephanie L. Fricke, Susan N. Payne, Peter F. Favreau et al. · Molecular Cancer Therapeutics · 2018 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K

Alexander E. Yueh, Susan N. Payne, Alyssa A. Leystra et al. · PLoS ONE · 2016 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 5